
CRH Medical Corporation Financial Statements 2011-2026 | CRHM
Annual Financial Statements CRH Medical Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
152 M | 273 M | 231 M | 209 M | 435 M | 174 M | 93.4 M | 31.2 M | 20 M | 31.2 M |
Shares |
71.5 M | 71.5 M | 72.6 M | 73.7 M | 71.8 M | 67.9 M | 48.9 M | 48.7 M | 48.7 M | 48.7 M |
Net Income |
-24.5 M | 3.77 M | 4.68 M | 6.56 M | 10.6 M | 3.08 M | 1.5 M | 2.49 M | 1.33 M | 1.2 M |
Revenue |
106 M | 120 M | 113 M | 100 M | 78.4 M | 46 M | 12 M | 7.68 M | 6.85 M | 5.53 M |
EBITDA |
33.9 M | 49.7 M | 51.8 M | 14.6 M | 24.8 M | 13.5 M | 3.87 M | 1.86 M | 1.42 M | 1.24 M |
Operating Expenses |
8.44 M | 6.55 M | 6.35 M | 6.32 M | 3.85 M | 5.11 M | 2.48 M | 1.72 M | 1.75 M | 3.12 M |
General and Administrative Expenses |
8.44 M | 6.55 M | 6.35 M | 6.3 M | 3.8 M | 5.05 M | 2.43 M | 1.66 M | 1.66 M | 3.04 M |
All numbers in USD currency
Main types of financial statements CRH Medical Corporation CRHMFinancial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.
- Income Statement
Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability. - Balance Sheet
Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
Liabilities — debts and other external sources of financing.
Equity — owners' capital and retained earnings. - Cash Flow Statement
Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
- IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
- GAAP — Generally Accepted Accounting Principles used in the United States.
- RAS — Russian Accounting Standards, used domestically in Russia.
Financial reporting CRH Medical Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.
In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.
Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.
Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.
Financial statements of other stocks in the Medical instruments industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | ||
|
Baxter International
BAX
|
$ 19.73 | 0.61 % | $ 10.1 B | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | ||
|
Repro Med Systems
KRMD
|
$ 5.45 | -1.27 % | $ 249 M | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | ||
|
Masimo Corporation
MASI
|
$ 136.25 | -1.03 % | $ 7.26 B | ||
|
Merit Medical Systems
MMSI
|
$ 80.24 | -0.32 % | $ 4.67 B | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
$ 8.39 | -1.29 % | $ 169 M | ||
|
Alcon
ALC
|
$ 81.15 | 0.91 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
$ 36.95 | -2.17 % | $ 1.74 B | ||
|
Haemonetics Corporation
HAE
|
$ 65.96 | -0.15 % | $ 3.32 B | ||
|
electroCore
ECOR
|
$ 7.1 | -2.07 % | $ 39.2 K | ||
|
STERIS plc
STE
|
$ 261.64 | 0.3 % | $ 25.8 B | ||
|
AngioDynamics
ANGO
|
$ 9.98 | -0.3 % | $ 408 M | ||
|
ICU Medical
ICUI
|
$ 150.03 | 0.5 % | $ 3.66 B | ||
|
InfuSystem Holdings
INFU
|
$ 8.05 | -0.74 % | $ 166 M | ||
|
The Cooper Companies
COO
|
$ 80.37 | -0.14 % | $ 16 B | ||
|
Harvard Bioscience
HBIO
|
$ 0.54 | -6.29 % | $ 22.9 M | ||
|
Glaukos Corporation
GKOS
|
$ 119.07 | -3.93 % | $ 5.77 B | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | ||
|
Utah Medical Products
UTMD
|
$ 61.65 | 1.33 % | $ 224 M | ||
|
iRhythm Technologies
IRTC
|
$ 148.99 | -1.88 % | $ 4.65 B | ||
|
LeMaitre Vascular
LMAT
|
$ 83.86 | -1.41 % | $ 1.88 B | ||
|
Intuitive Surgical
ISRG
|
$ 507.55 | -2.78 % | $ 180 B | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | ||
|
Microbot Medical
MBOT
|
$ 1.86 | -2.11 % | $ 19 M | ||
|
Nephros
NEPH
|
$ 4.39 | -2.66 % | $ 45.6 M | ||
|
Milestone Scientific
MLSS
|
$ 0.3 | 2.95 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
$ 23.39 | -2.87 % | $ 4.03 B | ||
|
OraSure Technologies
OSUR
|
$ 2.79 | 3.33 % | $ 208 M | ||
|
Pro-Dex
PDEX
|
$ 39.41 | -0.04 % | $ 130 M | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
$ 13.62 | 0.52 % | $ 654 M | ||
|
Becton, Dickinson and Company
BDX
|
$ 201.09 | -0.41 % | $ 57.8 B | ||
|
Repligen Corporation
RGEN
|
$ 156.37 | -2.3 % | $ 8.71 M | ||
|
ResMed
RMD
|
$ 257.61 | -0.04 % | $ 37.6 B | ||
|
BioLife Solutions
BLFS
|
$ 22.58 | -1.57 % | $ 1.04 B | ||
|
Stereotaxis
STXS
|
$ 2.33 | -6.43 % | $ 188 M | ||
|
Retractable Technologies
RVP
|
$ 0.71 | 0.76 % | $ 21.3 M | ||
|
STAAR Surgical Company
STAA
|
$ 18.94 | -1.1 % | $ 930 M | ||
|
Teleflex Incorporated
TFX
|
$ 105.48 | 0.14 % | $ 4.94 B | ||
|
West Pharmaceutical Services
WST
|
$ 232.65 | -1.37 % | $ 17 B | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.27 | -0.32 % | $ 2.49 B |